Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Research Support, U.S. Gov't, Non-P.H.S.1
- Research Support, U.S. Gov't, P.H.S.1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Natl Cancer Inst Monogr1
Search Results
Sort by
- BookRobert A Norman, Reena Rupani.Summary: This book serves as a useful clinical guide on integrative dermatology for dermatologists, internists, family practitioners, pediatricians, and anyone else charged with the care of the skin. The case-based format distinguishes this work from a reference-style textbook, allowing readers to relate the presented cases to their own patients. Integrative dermatology is a relatively newly-defined field but is steadily increasing in popularity. Clinical Cases in Integrative Dermatology provides insight for clinicians and patients in handling the skin, with each chapter serving as a springboard for further pursuit and more extensive training. It will enable those new to the field to begin to develop a literacy and competence, while the more experienced learner will find new ways to sharpen their diagnostic and treatment skills.
Contents:
Acne
Atopic Dermatitis
Psoriasis
Warts
Hyperhidrosis
Lichen Planus
Pruritus
Psychoneurodermatitis
Rosacea
Skin Cancer
Vitiligo
Alopecia Areata
Photo Aging
Stasis Dermatitis / Lymphedema
Telogen Effluvium
Notalgia Paresthetica
Hidradenitis Suppurativa
Allergic Contact Dermatitis
Raynauds
Lupus
Urticaria
Tinea
Candidiasis
Impetigo And MRSA Infections
Cosmetics.Digital Access Springer 2015 - ArticleCatalona WJ, Tarpley JL, Potvin C, Chretien PB.Natl Cancer Inst Monogr. 1978 Dec(49):105-10.We used delayed hypersensitivity skin testing, in vitro lymphocyte blastogenesis, and lymphocyte surface markers to examine the relationships among host immunologic competence, tumor type, tumor stage, prognosis, and the effects of cancer treatments in patients with genitourinary cancer. We found correlations between host immune competence and both tumor stage and prognosis among patients with bladder cancer, renal cell cancer, and those with advanced prostate cancer not receiving endocrine therapy, but not among patients with prostate cancer receiving endocrine therapy. Radiation and chemotherapy suppressed T-lymphocyte levels, but a chemotherapy-induced tumor remission resulted in a rebound of T-cell counts to above normal levels. In tissue sections of bladder cancers, regions of mononuclear infiltration were virtually devoid of cells with complement receptors or receptors for cytophilic antibody, which suggested that lymphocytes infiltrating bladder cancers are predominantly T-lymphocytes.